|
ASP2138 Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 1: 2
Top Sponsors
- Astellas Pharma Global Development, Inc.2
Indications
- Cancer2
- Gastroesophageal Junction (GEJ) Adenocarcinoma1
- Gastric Adenocarcinoma1
- Pancreatic Ductal Adenocarcinoma1
- Pancreatic Adenocarcinoma1
Orange, California1 trial
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
University of California Irvine Medical Center
Phase 1
Boston, Massachusetts1 trial
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Massachusetts General Hospital
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.